EE04040B1 - Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks - Google Patents

Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks

Info

Publication number
EE04040B1
EE04040B1 EE9700231A EE9700231A EE04040B1 EE 04040 B1 EE04040 B1 EE 04040B1 EE 9700231 A EE9700231 A EE 9700231A EE 9700231 A EE9700231 A EE 9700231A EE 04040 B1 EE04040 B1 EE 04040B1
Authority
EE
Estonia
Prior art keywords
treatment
cardiovascular diseases
aminotetraline
derivative
aminotetraline derivative
Prior art date
Application number
EE9700231A
Other languages
English (en)
Estonian (et)
Other versions
EE9700231A (et
Inventor
Chiesi Paolo
Bongrani Stefano
Razzetti Roberta
Civelli Maurizio
Umile Alberto
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of EE9700231A publication Critical patent/EE9700231A/xx
Publication of EE04040B1 publication Critical patent/EE04040B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EE9700231A 1995-03-17 1996-03-13 Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks EE04040B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95MI000532A IT1275935B1 (it) 1995-03-17 1995-03-17 Derivato di aminotetralina per la terapia di malattie cardiovascolari
PCT/EP1996/001060 WO1996029065A2 (en) 1995-03-17 1996-03-13 Aminotetralin derivative for the therapy of cardiovascular diseases

Publications (2)

Publication Number Publication Date
EE9700231A EE9700231A (et) 1998-04-15
EE04040B1 true EE04040B1 (et) 2003-06-16

Family

ID=11370947

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700231A EE04040B1 (et) 1995-03-17 1996-03-13 Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks

Country Status (31)

Country Link
US (2) US6013678A (xx)
EP (2) EP0814791B1 (xx)
JP (1) JPH11502211A (xx)
KR (1) KR100391143B1 (xx)
CN (1) CN1112920C (xx)
AT (1) ATE218856T1 (xx)
AU (1) AU702656B2 (xx)
BR (1) BR9607996A (xx)
CA (1) CA2215671A1 (xx)
CZ (1) CZ288488B6 (xx)
DE (1) DE69621786T2 (xx)
DK (1) DK0814791T3 (xx)
EA (1) EA000937B1 (xx)
EE (1) EE04040B1 (xx)
ES (1) ES2177769T3 (xx)
HK (2) HK1004802A1 (xx)
HU (1) HUP9801686A3 (xx)
IL (1) IL117518A (xx)
IT (1) IT1275935B1 (xx)
LT (1) LT4355B (xx)
LV (1) LV11882B (xx)
MX (1) MX9706971A (xx)
NO (1) NO317402B1 (xx)
NZ (1) NZ303993A (xx)
PL (1) PL183347B1 (xx)
PT (1) PT814791E (xx)
SI (1) SI9620036B (xx)
SK (1) SK282952B6 (xx)
TR (1) TR199700963T1 (xx)
WO (1) WO1996029065A2 (xx)
ZA (1) ZA962073B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2695157B2 (ja) * 1986-12-29 1997-12-24 松下電器産業株式会社 可変パイプラインプロセッサ
WO2000076544A1 (en) * 1996-03-13 2000-12-21 Chiesi Farmaceutici S.P.A. Aminotetralin derivative for the therapy of cardiovascular diseases
SI1183046T1 (en) * 1999-06-09 2004-02-29 Chiesi Farmaceutici S.P.A. Aminotetralin derivative for the therapy of cardiovascular diseases
MXPA01012638A (es) * 1999-06-09 2002-07-22 Chiesi Farma Spa Derivados de aminotetralina para la terapia de enfermedades cardiovasculares.
IT1313583B1 (it) * 1999-07-30 2002-09-09 Chiesi Farma Spa Derivati 2-amminotetralinici per la terapia del glaucoma.
IL152751A0 (en) * 2000-05-12 2003-06-24 Chiesi Farma Spa Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
SE0101854L (sv) * 2001-05-28 2002-11-29 Bioneris Ab Användning av en förening med en negativt laddad region av grupper för behandling av restenos.
EP1384708A1 (en) * 2002-07-26 2004-01-28 CHIESI FARMACEUTICI S.p.A. Process for the manufacture of form I of nolomirole hydrochloride
US20050101668A1 (en) * 2003-07-24 2005-05-12 Chiesi Farmaceutici S.P.A. Aminotetralin derivatives as a medicament for the treatment and prevention of myocardial ischemic conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134997A (en) * 1977-03-01 1979-01-16 University Of Iowa Research Foundation Effect of an aminotetralin derivative on coronary blood flow in infarcted hearts
SU998342A1 (ru) 1981-12-11 1983-02-23 Предприятие П/Я А-3732 Способ получени синтетического цеолита типа @
IT1218322B (it) * 1982-06-10 1990-04-12 Chiesi Farma Spa Derivati di 1,2,3,4-tetraidronaftalene,procedimento di preparazione e relative composizioni farmaceutiche

Also Published As

Publication number Publication date
LT4355B (lt) 1998-06-25
PL183347B1 (pl) 2002-06-28
DK0814791T3 (da) 2002-10-07
DE69621786D1 (de) 2002-07-18
EP0814791A1 (en) 1998-01-07
EP0814791B1 (en) 2002-06-12
LT97147A (en) 1998-02-25
ATE218856T1 (de) 2002-06-15
TR199700963T1 (xx) 1998-02-21
EE9700231A (et) 1998-04-15
HUP9801686A3 (en) 1999-10-28
ZA962073B (en) 1996-11-27
SK125497A3 (en) 1998-02-04
US6103760A (en) 2000-08-15
CZ286697A3 (cs) 1998-03-18
CZ288488B6 (en) 2001-06-13
CA2215671A1 (en) 1996-09-26
WO1996029065A2 (en) 1996-09-26
KR100391143B1 (ko) 2003-11-28
EA199700243A1 (ru) 1998-02-26
NZ303993A (en) 2000-12-22
NO974267L (no) 1997-11-07
ITMI950532A0 (it) 1995-03-17
LV11882B (en) 1998-03-20
SK282952B6 (sk) 2003-01-09
SI9620036A (sl) 1998-02-28
PL322284A1 (en) 1998-01-19
SI9620036B (sl) 2002-10-31
ES2177769T3 (es) 2002-12-16
ITMI950532A1 (it) 1996-09-17
IL117518A (en) 2001-05-20
IT1275935B1 (it) 1997-10-24
BR9607996A (pt) 1998-06-23
HK1004802A1 (en) 1998-12-11
JPH11502211A (ja) 1999-02-23
AU5107296A (en) 1996-10-08
EP1216702A2 (en) 2002-06-26
CN1181699A (zh) 1998-05-13
PT814791E (pt) 2002-10-31
WO1996029065A3 (en) 1996-11-28
DE69621786T2 (de) 2003-01-02
NO974267D0 (no) 1997-09-16
NO317402B1 (no) 2004-10-25
KR19980703030A (ko) 1998-09-05
MX9706971A (es) 1997-11-29
CN1112920C (zh) 2003-07-02
AU702656B2 (en) 1999-02-25
HK1048060A1 (zh) 2003-03-21
LV11882A (lv) 1997-12-20
HUP9801686A2 (hu) 1999-06-28
US6013678A (en) 2000-01-11
IL117518A0 (en) 1996-07-23
EA000937B1 (ru) 2000-06-26
EP1216702A3 (en) 2002-09-04

Similar Documents

Publication Publication Date Title
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
KR960702318A (ko) 근육 질병 및 장애의 치료방법
HUP9900773A3 (en) Use of carbazole derivatives for producing pharmaceutical compositions suitable for the treatment of congestive heart failure
NO20075065L (no) Anvendelse av isoflavonforbindelser til a behandle hjertesykdom
ITTO950104A0 (it) Catetere, particolarmente per il trattamento di aritmie cardiache.
IE791235L (en) Acyl-derivatives of carnitine.
ATE239474T1 (de) Verwendung von levobupivacain
ITTO950099A0 (it) Catetere, particolarmente per il trattamento di aritmie cardiache.
EE04040B1 (et) Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks
ATE157871T1 (de) Arzneimittel zur therapeutischen und prophylaktischen behandlung von krankheiten, die durch hyperplasie der glatten muskelzellen bedingt sind
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
ATE120447T1 (de) Polyamin-derivate als antineoplastische mittel.
TR199901385T2 (xx) Piperidin t�revleri.
GR3024707T3 (en) Digitoxigenin and dihydrodigitoxigenin 3beta-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders
GR3029466T3 (en) 1,5-disubstituted 7a-methylperhydroinden-3a-ol derivatives, active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
ATE236159T1 (de) Neuartige bispidin-derivate, die sich zur behandlung von herzrhythmusstörungen eignen
ATE78823T1 (de) 1,4-dihydro-5-isopropoxy-2-methyl-4-(2trifluormethyl-phenyl)-1,6-naphthyridin-3de890301
IT8421753A0 (it) Agenti terapeutici per il trattamento di disturbi cardiaci edella circolazione, delle dislipidemie e delle deficienze delle prestazioni muscolari, procedimento per la loro preparazione e relative composizioni farmaceutiche.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

MM4A Lapsed by not paying the annual fees

Effective date: 20050313